Get startedLog in
    Picture of CNS Pharmaceuticals logo

    CNSP — CNS Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: CNS Announces FDA Has Granted Orphan Drug Designation For Brain Cancer Drug Berubicin

    Picture of CNS Pharmaceuticals logoCNS Pharmaceuticals
    11/06/2020 13:23
    June 11 (Reuters) - CNS Pharmaceuticals Inc  CNSP.O :
    * CNS ANNOUNCES THE FDA HAS GRANTED ORPHAN DRUG DESIGNATION
FOR
BRAIN CANCER DRUG BERUBICIN

Source text for Eikon:  ID:nPnccj6LFa 
Further company coverage:  CNSP.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on CNS Pharmaceuticals

    See all news